GVB Biopharma has launched sales of cannabigerolic acid isolates, popularly known as CBGa.

CBGa is the carboxylic acid form of cannabigerol, known as CBG. It is a precursor molecule to delta-9-tetrahydrocannabinol, one of the primary psychoactive cannabinoids in Cannabis sativa. CBGa is non-intoxicating and has unique benefits described by scientific literature and by consumers. CBGa is important for cannabinoid research and production.

Recently, CBGa has been the focus of research studies on COVID-19 transmission and on epilepsy management. In January, a study conducted by Oregon State University was published in the peer-reviewed Journal of Natural Products. The research indicated CBGa has the potential to prevent cellular transmission of the SARS-CoV-2 coronavirus that causes COVID-19. A study published in the British Journal of Pharmacology last August demonstrated that CBGa had potent anti-seizure effects in certain mouse models of epilepsy.

GVB Biopharma's CBGa isolate product contains 95–99% CBGa.

Want more legal cannabis market news and information?
Join Cannabis Products on Facebook, Twitter, YouTube, and LinkedIn today!